Ingrid Autran

Ingrid Autran is a medical doctor and researcher at Østfold Hospital, where she is part of the PsykForsk research group, involved in studies on both MDMA-assisted therapy and ketamine. She has several years of clinical experience using intravenous ketamine for treatment-resistant depression in both public and private mental health care. Her PhD project focuses on ketamine treatment for treatment-resistant depression, with focus on investigating real-world outcomes, clinical predictors of response, and health economic aspects. In addition to her academic work, she is the founder of Aurora Clinics and Safe Space, a harm reduction initiative focused on psychedelic-informed care and public education.